The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Morbidity before and after the Diagnosis of Hyperthyroidism: A Nationwide Register-Based Study
Open accessAbstract
BACKGROUND: Hyperthyroidism has been linked with different morbidities, like atrial fibrillation, stroke and diabetes mellitus. However, our knowledge regarding the extent and temporal relation between hyperthyroidism and other diseases is fragmented. Here, we aimed at evaluating various morbidities before and after the diagnosis of hyperthyroidism. METHODS: Observational cohort study. From nationwide Danish health registers 2631 hyperthyroid singletons and 375 twin pairs discordant for hyperthyroidism were identified and followed for an average of 6 years (range 0-13). Data on the occurrence of cardiovascular diseases, lung diseases, diabetes mellitus, rheumatic diseases and malignant diseases was obtained by person-to-person record linkage with the National Danish Patient Register and/or the Danish National Prescription Registry (lung diseases and diabetes mellitus). Logistic and Cox regression models were used to assess the risk of morbidity before and after the diagnosis of hyperthyroidism, respectively. All Cox regression analyses were adjusted for the degree of co-morbidity preceding the diagnosis of hyperthyroidism, using the Charlson score. RESULTS: Hyperthyroid individuals had a significantly higher risk of being diagnosed with cardiovascular diseases (odds ratio (OR) 1.65; 95% confidence interval (CI): 1.45-1.87), lung diseases (OR 1.53; 95% CI: 1.29-1.60), and diabetes mellitus (OR 1.43, 95% CI: 1.20-1.72), but not with malignant diseases (OR 1.16, 95% CI: 0.99-1.36) prior to the diagnosis of hyperthyroidism. After the diagnosis of hyperthyroidism, subjects had a significantly higher risk of being diagnosed with cardiovascular diseases (hazard ratio (HR) 1.34; 95% CI: 1.15-1.56), lung diseases (HR 1.28; 95% CI: 1.10-1.49), and diabetes mellitus (HR 1.46; 95% CI: 1.16-1.84), but not with rheumatic diseases (HR 1.39, 95% CI: 0.92-2.09) or malignant diseases (HR 1.18, 95% CI 0.97-1.42). CONCLUSIONS: We demonstrate a significantly increased burden of morbidity, both before and after the diagnosis of hyperthyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An elevated risk of T2DM in patients with hyperthyroidism has been documented (6, 7).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A number of studies have reported the rising incidence of diabetes mellitus in patients with thyroid hormone dysregulation and vice versa (6, 7).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Thus, overtreatment of hypothyroidism most likely carries a similar risk of increased morbidity (39,40) and mortality, (41) as shown for hyperthyroidism.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Limitations of the Application of Fourfold Table Analysis to Hospital Data
Berkson, J. (1946) · Biometrics Bulletin · doi:10.2307/3002000 · Cited by 1,810
Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum‐Hansen, H. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399956 · Cited by 1,089
Boelaert, K., Newby, P. R., Simmonds, M. J., Holder, R. L., Carr-Smith, J. D., Heward, J. M., Manji, N., Allahabadia, A., Armitage, M., Chatterjee, K. V., et al. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.06.030 · Cited by 480
Effects of Thyroid Hormone on the Cardiovascular System
Fazio, S. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.31 · Cited by 445
Brix, T. H., Kyvik, K. O., Christensen, K., & Hegedűs, L. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7242 · Cited by 425
Self-citationCooper, D. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14073-1 · Cited by 384
LAURBERG, P., PEDERSEN, K. M., VESTERGAARD, H., & SIGURDSSON, G. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00368.x · Cited by 361
Selmer, C., Olesen, J. B., Hansen, M. L., Lindhardsen, J., Olsen, A.-M. S., Madsen, J. C., Faber, J., Hansen, P. R., Pedersen, O. D., Torp-Pedersen, C., et al. (2012) · BMJ · doi:10.1136/bmj.e7895 · Cited by 323
Brix, T. H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.930 · Cited by 311
Self-citation
Research works printed but not linked: 1
- Rothman XJ, Greenland S, Lash TL (2008) Modern Epidemiology: Case Control studies. Lippincott Williams & Wilkins. Philadelphia 2008.
Cited by
Sorted by citations
Gharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedűs, L. D., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,285
Self-citationSmith, T. J., & Hegedűs, L. D. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,338
Self-citationThyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationSelmer, C., Olesen, J. B., Hansen, M. L., von Kappelgaard, L. M., Madsen, J. C., Hansen, P. R., Pedersen, O. D., Faber, J., Torp-Pedersen, C., & Gislason, G. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4184 · Cited by 288
Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study
Chaker, L., Ligthart, S., Korevaar, T. I. M., Albert Hofman, D., Franco, O. H., Peeters, R. P., & Dehghan, A. (2016) · BMC Medicine · doi:10.1186/s12916-016-0693-4 · Cited by 194
Perros, P., Hegedűs, L. D., Bartalena, L., Marcocci, C., Kahaly, G. J., Baldeschi, L., Salvi, M., Lazarus, J. H., Eckstein, A. K., Pitz, S., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0625-1 · Cited by 171
Self-citationLinks between Thyroid Disorders and Glucose Homeostasis
Eom, Y. S., Wilson, J. R., & Bernet, V. J. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0013 · Cited by 182
Thyroid hormones in diabetes, cancer, and aging
Gauthier, B. R., Sola‐García, A., Cáliz‐Molina, M. Á., Lorenzo, P. I., Cobo‐Vuilleumier, N., Capilla‐González, V., & Martín‐Montalvo, A. (2020) · Aging Cell · doi:10.1111/acel.13260 · Cited by 153
Thvilum, M., Brandt, F., Almind, D., Christensen, K., Brix, T. H., & Hegedűs, L. D. (2014) · Thyroid · doi:10.1089/thy.2013.0555 · Cited by 125
Self-citationHyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women
Journy, N., Bernier, M., Doody, M. M., Alexander, B. H., Linet, M. S., & Kitahara, C. M. (2017) · Thyroid · doi:10.1089/thy.2017.0063 · Cited by 119
Abrahamsen, B., Jørgensen, H. L., Laulund, A. S., Nybo, M., Brix, T. H., & Hegedüs, L. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2244 · Cited by 112
Self-citationLillevang‐Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedűs, L. D. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00166 · Cited by 114
Self-citationHyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0708 · Cited by 111
Self-citationLillevang-Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedüs, L. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0006 · Cited by 100
Self-citationLillevang‐Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedűs, L. D. (2019) · Thyroid · doi:10.1089/thy.2018.0320 · Cited by 103
Self-citationThyroid dysfunction and cancer incidence: a systematic review and meta-analysis
Tran, T., Kitahara, C. M., de Vathaire, F., Boutron‐Ruault, M., & Journy, N. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0417 · Cited by 103
Abrahamsen, B., Jørgensen, H. L., Laulund, A. S., Nybo, M., Bauer, D. C., Brix, T. H., & Hegedüs, L. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2416 · Cited by 98
Self-citationThyroid Function and the Risk of Prediabetes and Type 2 Diabetes
Dueñas, O. H. R., van der Burgh, A. C., Ittermann, T., Ligthart, S., Ikram, M. A., Peeters, R. P., & Chaker, L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac006 · Cited by 93
Dekkers, O. M., Horváth–Puhó, E., Cannegieter, S. C., Vandenbroucke, J. P., Sørensen, H. T., & Jørgensen, J. O. L. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0576 · Cited by 85
Papini, E., Pacella, C. M., Misischi, I., Guglielmi, R., Bizzarri, G., Døssing, H., & Hegedűs, L. D. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.02.004 · Cited by 77
Self-citationCramon, P. K., Winther, K. H., Watt, T., Bonnema, S. J., Bjørner, J. B., Ekholm, O., Grøenvold, M., Hegedűs, L. D., Feldt‐Rasmussen, U., & Rasmussen, Å. K. (2016) · Thyroid · doi:10.1089/thy.2016.0044 · Cited by 77
Self-citationDuration of Thyroid Dysfunction Correlates with All-Cause Mortality. The OPENTHYRO Register Cohort
Laulund, A. S., Nybo, M., Brix, T. H., Abrahamsen, B., Jørgensen, H. L., & Hegedüs, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110437 · Cited by 70
Self-citationBove, K. B., Watt, T., Vogel, A., Hegedűs, L. D., Bjoerner, J. B., Grøenvold, M., Bonnema, S. J., Rasmussen, Å. K., & Feldt‐Rasmussen, U. (2014) · European Thyroid Journal · doi:10.1159/000365211 · Cited by 70
Self-citationDeath by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study
Ferløv-Schwensen, C., Brix, T. H., & Hegedűs, L. D. (2017) · Thyroid · doi:10.1089/thy.2017.0365 · Cited by 70
Self-citationFolkestad, L., Brandt, F., Lillevang‐Johansen, M., Brix, T. H., & Hegedűs, L. D. (2020) · Thyroid · doi:10.1089/thy.2019.0672 · Cited by 63
Self-citationNexø, M. A., Watt, T., Pedersen, J., Bonnema, S. J., Hegedűs, L. D., Rasmussen, Å. K., Feldt‐Rasmussen, U., & Bjørner, J. B. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4468 · Cited by 64
Self-citationRyödi, E., Metso, S., Huhtala, H., Välimäki, M. J., Auvinen, A. P., & Jaatinen, P. (2018) · Thyroid · doi:10.1089/thy.2017.0461 · Cited by 58
Kim, H. J., Kang, T., Kang, M. J., Ahn, H. S., & Sohn, S. Y. (2020) · Thyroid · doi:10.1089/thy.2019.0543 · Cited by 50
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Gu, L., Yang, J., Gong, Y., Ma, Y., Yan, S., Huang, Y., Wang, Y., & Peng, Y. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13118 · Cited by 43
Graves Disease and Inflammatory Bowel Disease: A Bidirectional Mendelian Randomization
Xian, W., Wu, D., Liu, B., Hong, S., Huo, Z., Xiao, H., & Li, Y. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac683 · Cited by 44
Thvilum, M., Brandt, F., Brix, T. H., & Hegedűs, L. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1407 · Cited by 44
Self-citationHow patients experience thyroid eye disease
Smith, T. J., Hegedűs, L. D., Lesser, I. M., Perros, P., Dorris, K., Kinrade, M., Troy-Ott, P., Wuerth, L., & Nori, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1283374 · Cited by 36
Self-citationThyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus
on behalf of the SMART study group, de Vries, T. I., Kappelle, L. J., van der Graaf, Y., de Valk, H. W., de Borst, G. J., Nathoe, H. M., Visseren, F. L. J., & Westerink, J. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1231-y · Cited by 32
Aging under endocrine hormone regulation
Xing, Y., Fan, X., Wang, K., & Zhang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1223529 · Cited by 33
Exploring the Experiences of People With Hypo- and Hyperthyroidism
Nexø, M. A., Watt, T., Cleal, B. R., Hegedűs, L. D., Bonnema, S. J., Rasmussen, Å. K., Feldt‐Rasmussen, U., & Bjørner, J. B. (2014) · Qualitative Health Research · doi:10.1177/1049732314554093 · Cited by 32
Self-citationThe role of radioiodine therapy in benign nodular goitre
Bonnema, S. J., Fast, S., & Hegedűs, L. D. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.02.001 · Cited by 30
Self-citationBrito, J. P., Nagy, E. V., Ospina, N. S., Zˇarković, M., Dosiou, C., Fichter, N., Lucarelli, M. J., & Hegedűs, L. D. (2022) · Thyroid · doi:10.1089/thy.2022.0172 · Cited by 31
Self-citationGiesecke, P., Rosenqvist, M., Frykman, V., Friberg, L., Wallin, G., Höijer, J., Lönn, S., & Törring, O. (2017) · Thyroid · doi:10.1089/thy.2017.0029 · Cited by 27
Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy
Caputo, M., Pecere, A., Sarro, A., Mele, C., Ucciero, A., Pagano, L., Prodam, F., Aimaretti, G., Marzullo, P., & Barone‐Adesi, F. (2020) · Endocrine · doi:10.1007/s12020-020-02222-7 · Cited by 27
Influence of iodization programmes on the epidemiology of nodular goitre
Fiore, E., Tonacchera, M., & Vitti, P. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.04.002 · Cited by 27
Increased risk of postoperative complications after total thyroidectomy with Graves' disease
Kwon, H., Kim, J., Lim, W., Moon, B., & Paik, N. S. (2018) · Head & Neck · doi:10.1002/hed.25484 · Cited by 27
Nicolaisen, P., Obling, M. L., Winther, K. H., Hansen, S., Hermann, A. P., Hegedűs, L. D., Bonnema, S. J., & Brix, T. H. (2020) · Thyroid · doi:10.1089/thy.2020.0084 · Cited by 24
Self-citationKwon, H., & Moon, B.-I. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-02044-x · Cited by 25
The association between serum concentration of thyroid hormones and thyroid cancer: a cohort study
Kim, T. H., Lee, M. Y., Jin, S. M., & Lee, S. H. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0094 · Cited by 24
Thyroid Disease as a Risk Factor for Cerebrovascular Disease
Yang, M.-H., Yang, F.-Y., & Lee, D. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.11.032 · Cited by 24
Brandt, F., Thvilum, M., Hegedűs, L. D., & Brix, T. H. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0306 · Cited by 26
Self-citationTuran, E., & Karaaslan, Ö. (2020) · Oman Medical Journal · doi:10.5001/omj.2020.84 · Cited by 23
The role of Graves’ disease in the development of thyroid nodules and thyroid cancer
Soares, M., Borges‐Canha, M., Neves, C., Neves, J. S., & Carvalho, D. M. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0055 · Cited by 27
Ferløv-Schwensen, C., Brandt, F., Hegedűs, L. D., & Brix, T. H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0954 · Cited by 23
Self-citationThe efficiency and safety of methimazole and propylthiouracil in hyperthyroidism
Tan, S., Chen, L., Jin, L., & Fu, X. (2021) · Medicine · doi:10.1097/md.0000000000026707 · Cited by 25
Merke, A., Merke, J., Silbernagel, G., & März, W. (2016) · Endocrine Practice · doi:10.4158/ep161217.or · Cited by 20
Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review
Palella, M., Giustolisi, F. M., Fiascaro, A. M., Fichera, M., Palmieri, A., Cannarella, R., Calogero, A. E., Ferrante, M., & Fiore, M. (2023) · Cancers · doi:10.3390/cancers15102724 · Cited by 22
Burlacu, M., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Papini, E., Perros, P., Sawadogo, K. A., Bex, M., Corvilain, B., Daumerie, C., et al. (2022) · Thyroid Research · doi:10.1186/s13044-022-00121-9 · Cited by 20
Self-citationRisk of Diabetes in Patients with Long-Standing Graves’ Disease: A Longitudinal Study
Song, E., Koo, M. J., Noh, E., Hwang, S. Y., Park, M., Kim, J. A., Roh, E., Choi, K. M., Baik, S. H., Cho, G. J., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1251 · Cited by 18
Ali, S. A., Ersbøll, M. K., Vinding, N. E., Butt, J. H., Rørth, R., Selmer, C., Westergaard, L. M., Mogensen, U. M., Weeke, P. E., Jøns, C., et al. (2022) · EP Europace · doi:10.1093/europace/euac217 · Cited by 18
Hyperthyroidism and cardiovascular disease: an association study using big data analytics
Iglesias, P., Benavent, M., López, G., Arias, J., Romero, I., & Díez, J. J. (2023) · Endocrine · doi:10.1007/s12020-023-03482-9 · Cited by 18
Larsen, C. B., Riis, K. R., Winther, K. H., Larsen, E. L., Ellervik, C., Hegedűs, L. D., Brix, T. H., Poulsen, H. E., & Bonnema, S. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab273 · Cited by 17
Self-citationPatients with Benign Thyroid Diseases Experience an Impaired Sex Life
Sawicka‐Gutaj, N., Ruchała, M., Feldt‐Rasmussen, U., Rasmussen, Å. K., Hegedűs, L. D., Bonnema, S. J., Grøenvold, M., Bjørner, J. B., & Watt, T. (2018) · Thyroid · doi:10.1089/thy.2017.0602 · Cited by 18
Self-citationAdolescent Thyroid Disorders and Risk for Type 2 Diabetes in Young Adulthood
Bardugo, A., Derazne, E., Zucker, I., Bendor, C. D., Puris, G., Lutski, M., Pinhas‐Hamiel, O., Cukierman‐Yaffe, T., Mosenzon, O., Schechter, M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab382 · Cited by 16
Kim, S. Y., Yoo, D. M., Min, C., & Choi, H. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163522 · Cited by 14
Ratzon, N. Z., Uziely, B., de Boer, A. G. E. M., & Rottenberg, Y. (2016) · Thyroid · doi:10.1089/thy.2015.0608 · Cited by 13
Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration
Galofré, J. C., Díez, J. J., Attanasio, R., Nagy, E. V., Negro, R., Papini, E., Perros, P., Žarković, M., Akarsu, E., Alevizaki, M. K., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02409-z · Cited by 14
Self-citationCassemiro, J. F., Ilera, V., Batallés, S. M., Reyes, A., Nagy, E. V., Papini, E., Perros, P., Hegedűs, L. D., & Ramos, H. E. (2023) · Thyroid Research · doi:10.1186/s13044-023-00182-4 · Cited by 13
Self-citationde Vries, T. I., de Valk, H. W., van der Graaf, Y., de Borst, G. J., Cramer, M. J., Kappelle, L. J., Visseren, F. L. J., & Westerink, J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107880 · Cited by 10
Brix, T. H., & Hegedűs, L. D. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000654 · Cited by 11
Self-citationRiis, T., Bonnema, S. J., Brix, T. H., & Folkestad, L. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0181 · Cited by 9
Self-citationMortality Risk After Radioiodine Therapy for Hyperthyroidism: A Systematic Review and Meta-Analysis
Yan, D., Chen, C., Yan, H., Liu, T., Yan, H., & Yuan, J. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.10.018 · Cited by 9
Ayvaz, G., Akarsu, E., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Papini, E., & Perros, P. (2022) · Endocrinology research and practice. · doi:10.5152/tjem.2022.22024 · Cited by 9
Self-citationFolkestad, L., Brandt, F., Brix, T. H., Vogsen, M., Bastholt, L., Grupe, P., Petersen, J. K., & Hegedűs, L. D. (2017) · European Thyroid Journal · doi:10.1159/000479061 · Cited by 9
Self-citationShi, W., Song, D., Chen, D., Duan, W., & Zhang, J. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej22-0643 · Cited by 8
Prevalence of diabetes in people with thyroid dysfunction
Díez, J. J., & Iglesias, P. (2023) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.09.023 · Cited by 8
Prevalencia de diabetes en personas con disfunción tiroidea
Díez, J. J., & Iglesias, P. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.09.022 · Cited by 8
Hypothyroidism: playing the cardiometabolic risk concerto
Kahaly, G. J., Liu, Y., & Persani, L. (2025) · Thyroid Research · doi:10.1186/s13044-025-00233-y · Cited by 11
Amirabadizadeh, A., Ghorbani, A., Azizi, F., Abdi, H., Amouzegar, A., & Mehran, L. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01612-w · Cited by 7
Chen, J., Liang, H., Tan, Y., Wen, L., Guo, Z., Nie, J., Lin, X., Huang, F., Wang, J., Xing, P., et al. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127144 · Cited by 7
Association Between Serum Levels of Adipocyte Fatty Acid-binding Protein and Free Thyroxine
Tseng, F., Chen, P., Chen, Y.-T., Chi, Y.-C., Shih, S., Wang, C., Chen, C., & Yang, W. (2015) · Medicine · doi:10.1097/md.0000000000001798 · Cited by 7
The progression of secondary diabetes: A review of modeling studies
Yang, B., Li, J., Haller, M. J., Schatz, D. A., & Rong, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1070979 · Cited by 6
“An elevated risk of T2DM in patients with hyperthyroidism has been documented (6, 7).”
BackgroundKlit, F. Ø., Dal, J., Andersen, S. L., Nikontovic, A., Vestergaard, P., & Karmisholt, J. (2024) · Clinical Epidemiology · doi:10.2147/clep.s484335 · Cited by 6
Chopra, R., Kalaria, T., Gherman‐Ciolac, C., Raghavan, R., Buch, H., & Kar, N. (2023) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_474_22 · Cited by 7
Nexø, M. A., Watt, T., Bonnema, S. J., Hegedűs, L. D., Rasmussen, Å. K., Feldt‐Rasmussen, U., & Bjørner, J. B. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0896-0 · Cited by 6
Self-citationTseng, F., Chen, Y.-T., Chi, Y., Chen, P., & Yang, W. (2018) · Medicine · doi:10.1097/md.0000000000013254 · Cited by 6
Enhanced Well-Being Associated with Thyrotoxicosis: A Neglected Effect of Thyroid Hormones?
Perros, P., & Hegedűs, L. D. (2022) · Intern J Endocrinol Metab · doi:10.5812/ijem-127230 · Cited by 5
Self-citationType 2 diabetes and thyroid cancer: Synergized risk with rising air pollution
Kruger, E. M., Shehata, S. A., Toraih, E. A., Abdelghany, A. A., & Fawzy, M. S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.1037 · Cited by 5
Toxic Adenoma and Multinodular Toxic Goiter
Tonacchera, M., & Führer, D. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_18 · Cited by 5
Choi, Y. J., Han, K., Cho, W. K., Jung, M. H., & Suh, B. (2023) · Clinical Epidemiology · doi:10.2147/clep.s406361 · Cited by 5
Li, M., Yang, X., Li, R., Wu, B., Hao, J., Qi, Y., Bai, T., Yang, L., Zhang, Y., & Liu, Y. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s458486 · Cited by 5
Wang, Q., Li, C., Di, S., Han, L., Zhao, L., & Tong, X. (2018) · Medicine · doi:10.1097/md.0000000000013076 · Cited by 5
Low-Normal Free Thyroxine Levels in Euthyroid Male Are Associated with Prediabetes
Kim, S. W., Jeon, J., Moon, J. S., Jeon, E. J., Kim, M.-K., Lee, I., Seo, J. B., & Park, K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0222 · Cited by 6
Barrea, L., Caprio, M., Perrini, S., Camajani, E., Crafa, A., Gangitano, E., Gorini, S., Sciacca, L., Verde, L., Albertelli, M., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02589-2 · Cited by 5
Krysiak, R. G., Kowalcze, K. E., & Okopień, B. (2024) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.6144 · Cited by 4
Lin, C., Chang, C.-K., Shih, C.-W., Li, H., Chen, K., Yang, W., Tsai, K., Wang, C., & Shih, S. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05116-1 · Cited by 4
Brandt, F., Thvilum, M., Hegedűs, L. D., & Brix, T. H. (2017) · Endocrine · doi:10.1007/s12020-017-1485-0 · Cited by 4
Self-citationVisceral and Subcutaneous Fat Increased after Treatment of Graves Disease
Ito, A., Ando, T., Nozaki, A., Haraguchi, A., Horie, I., & Kawakami, A. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0459 · Cited by 3
Liew, H., Watt, T., Nan, L., Tan, A. W. K., Chan, Y. H., Chew, D. E. K., & Dalan, R. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00309-x · Cited by 3
Liu, A., Morrison, D., Hegedűs, L. D., Nagy, E. V., Papini, E., Perros, P., Attanasio, R., Negro, R., Uum, S. H. M. V., Nygaard, B., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.70009 · Cited by 4
Self-citationOPG is associated with thyroid nodule development in type 2 diabetes
Huang, D., Niu, Y., Zhang, W., Li, X., Lin, N., Yang, Z., Qin, L., Su, Q., Ran, H., & Zhang, H. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24615 · Cited by 3
Şahi̇n, M., Demirci, İ., Haymana, C., Taşçı, İ., Emral, R., Çakal, E., Ünlütürk, U., Satman, İ., Demir, T., Ata, N., et al. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1971-8781 · Cited by 3
Zheng, S., Wang, Z., Yang, L., & Zhang, X. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05150-8 · Cited by 3
Metadata
- Authors
- Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H.
- Affiliations
- Odense University Hospital (DK)
- University of Southern Denmark (DK)
- Corresponding author
- Brandt, Frans
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-06-20
- Volume
- 8
- Issue
- 6
- Pages
- e66711
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3688572
- OpenAlex
- W2044489693
- Cited by
- 142
- References
- 44
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 10 · 2023: 15 · 2022: 17 · 2021: 13 · 2020: 17 · 2019: 6 · 2018: 12 · 2017: 11 · 2016: 8 · 2015: 9 · 2014: 15 · 2013: 1
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Novo Nordisk
- Syddansk Universitet
- Novo Nordisk Fonden
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Keywords
- hyperthyroidism, comorbidities, cardiovascular disease, lung disease, diabetes mellitus, rheumatic diseases, cancer, atrial fibrillation, stroke, hyperthyroidism diagnosis, twin discordance, Charlson Comorbidity Index, Denmark, patient registry, data linkage
- MeSH terms
- Aged, Cardiovascular Diseases, Denmark, Diabetes Mellitus, Female, Humans, Hyperthyroidism, Lung Diseases, Male, Middle Aged, Morbidity, Registries, Time Factors, Cohort Studies, Logistic Models, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
